image

The best stocks to buy since 1993

Latest issue now available

Fulcrum Pharna - Set to expamd in US, Europe and Japan

July 2002

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FUL
During the month we met with chief executive Jon Court. This followed the announcement of Fulcrum's interim results last month whichwas accompanied by news of a share placing. Fulcrum is avirtual drug development services business offering a strategicoutsourcing service to the pharmaceutical industry. As a virtual drugdeveloper, it coordinates a company's outsourced R&D, across thefull length of the drug development value chain, from the identification of a lead candidate through to global approval. Its consultants will liaise with contract research organisations (CROs), contract manufacturers and suppliers, to assemble and head teams which will co-ordinate the development of individual drug research programs. At ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe